These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31314741)

  • 1. Reply to comments on "State of the art in magnetic resonance imaging of hepatocellular carcinoma": the role of DWI.
    Horvat N; Monti S; Oliveira BC; Rocha CCT; Giancipoli RG; Mannelli L
    Radiol Oncol; 2019 Jul; 53(3):371-372. PubMed ID: 31314741
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "State of the art in magnetic resonance imaging of hepatocellular carcinoma": the role of DWI.
    Granata V; Fusco R; Filice S; Incollingo P; Belli A; Izzo F; Petrillo A
    Radiol Oncol; 2019 Jul; 53(3):369-370. PubMed ID: 31318697
    [No Abstract]   [Full Text] [Related]  

  • 3. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
    Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
    Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI.
    Schelhorn J; Best J; Reinboldt MP; Dechêne A; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Magn Reson Imaging; 2015 Sep; 42(3):818-27. PubMed ID: 25515676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules.
    Di Pietropaolo M; Briani C; Federici GF; Marignani M; Begini P; Delle Fave G; Iannicelli E
    Clin Imaging; 2015; 39(3):468-75. PubMed ID: 25748089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
    Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
    PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of Gd-EOB-DTPA-Enhanced MRI and Diffusion-Weighted Imaging in Detecting Residual Hepatocellular Carcinoma After Drug-Eluting Bead Transarterial Chemoembolization.
    Liu HF; Xu YS; Liu Z; Che KY; Sheng Y; Ding JL; Zhang JG; Lei JQ; Xing W
    Acad Radiol; 2021 Jun; 28(6):790-798. PubMed ID: 32414638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
    Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
    World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conspicuity of Malignant Liver Tumors on Diffusion-Weighted Imaging With Short tau Inversion Recovery After Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid Administration.
    Iwanaga T; Fukukura Y; Saito T; Sasaki M; Kumagae Y; Takumi K; Hakamada H; Fujisaki T; Saigo Y; Yoshiura T
    J Magn Reson Imaging; 2019 Feb; 49(2):565-573. PubMed ID: 30102432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients.
    Park MS; Kim S; Patel J; Hajdu CH; Do RK; Mannelli L; Babb JS; Taouli B
    Hepatology; 2012 Jul; 56(1):140-8. PubMed ID: 22370974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to: "Conclusive HCC diagnosis with hepatocyte-specific contrast-enhanced magnetic resonance imaging? Not yet".
    Choi SH; Byun JH
    J Hepatol; 2016 Sep; 65(3):650-1. PubMed ID: 27349489
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric Gd-EOB-DTPA magnetic resonance in diagnosis of HCC: dynamic study, hepatobiliary phase, and diffusion-weighted imaging compared to histology after orthotopic liver transplantation.
    Faletti R; Cassinis MC; Fonio P; Bergamasco L; Pavan LJ; Rapellino A; David E; Gandini G
    Abdom Imaging; 2015 Jan; 40(1):46-55. PubMed ID: 24965896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable?
    Kinner S; Umutlu L; Blex S; Maderwald S; Antoch G; Ertle J; Gerken G; Lauenstein TC
    Eur J Radiol; 2012 Apr; 81(4):e625-8. PubMed ID: 22297185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
    Ding Y; Rao SX; Chen C; Li R; Zeng MS
    Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging and diffusion-weighted MR imaging in predicting microvascular invasion in hepatocellular carcinoma and the prognostic significance].
    Zhu YJ; Feng B; Wang BZ; Wang S; Ye F; Ma XH; Zhao XM
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):312-317. PubMed ID: 33752311
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: is there a 'precursor' HCC lesion and can it be detected by hepatobiliary contrast-enhanced magnetic resonance imaging? Authors' reply.
    Toyoda H; Yasuda S; Shiota S
    Aliment Pharmacol Ther; 2021 Jul; 54(2):204-205. PubMed ID: 34170540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.